Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

A Randomized, Placebo-Controlled Trial of Omega-3 Fatty Acids for Inhibition of Supraventricular Arrhythmias After Cardiac Surgery: The FISH Trial.

Sandesara CM, Chung MK, Van Wagoner DR, Barringer TA, Allen K, Ismail HM, Zimmerman B, Olshansky B.

J Am Heart Assoc. 2012 Jun;1(3):e000547. doi: 10.1161/JAHA.111.000547. Epub 2012 Jun 22.

2.

Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.

Mozaffarian D, Marchioli R, Macchia A, Silletta MG, Ferrazzi P, Gardner TJ, Latini R, Libby P, Lombardi F, O'Gara PT, Page RL, Tavazzi L, Tognoni G; OPERA Investigators.

JAMA. 2012 Nov 21;308(19):2001-11. Erratum in: JAMA. 2013 Mar 6;309(9):876.

3.

Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.

Saravanan P, Bridgewater B, West AL, O'Neill SC, Calder PC, Davidson NC.

Circ Arrhythm Electrophysiol. 2010 Feb;3(1):46-53. doi: 10.1161/CIRCEP.109.899633. Epub 2009 Dec 30.

4.

Ω-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery: A Randomized, Controlled Trial.

Hoang A, Canada T.

Nutr Clin Pract. 2006 Apr;21(2):189-190. doi: 10.1177/0115426506021002189.

PMID:
28094674
5.

N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.

Calò L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, Meo A, Pandozi C, Staibano M, Santini M.

J Am Coll Cardiol. 2005 May 17;45(10):1723-8.

6.

Omega-3 fatty acids do not alter P-wave parameters in electrocardiogram or expression of atrial connexins in patients undergoing coronary artery bypass surgery.

Saravanan P, West AL, Bridgewater B, Davidson NC, Calder PC, Dobrzynsky H, Trafford A, O'Neill SC.

Europace. 2016 Oct;18(10):1521-1527. Epub 2016 Feb 5.

PMID:
26850746
7.

Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis.

Costanzo S, di Niro V, Di Castelnuovo A, Gianfagna F, Donati MB, de Gaetano G, Iacoviello L.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):906-11. doi: 10.1016/j.jtcvs.2013.03.015. Epub 2013 Apr 12. Review.

8.

Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study.

Heidt MC, Vician M, Stracke SK, Stadlbauer T, Grebe MT, Boening A, Vogt PR, Erdogan A.

Thorac Cardiovasc Surg. 2009 Aug;57(5):276-80. doi: 10.1055/s-0029-1185301. Epub 2009 Jul 23.

PMID:
19629889
9.

Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.

Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G, Doval HC; GESICA Investigators.

J Am Coll Cardiol. 2013 Jan 29;61(4):463-8. doi: 10.1016/j.jacc.2012.11.021. Epub 2012 Dec 19.

10.

n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.

Bianconi L, Calò L, Mennuni M, Santini L, Morosetti P, Azzolini P, Barbato G, Biscione F, Romano P, Santini M.

Europace. 2011 Feb;13(2):174-81. doi: 10.1093/europace/euq386. Epub 2010 Nov 8.

PMID:
21059740
11.

Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial.

Wu JH, Marchioli R, Silletta MG, Macchia A, Song X, Siscovick DS, Harris WS, Masson S, Latini R, Albert C, Brown NJ, Lamarra M, Favaloro RR, Mozaffarian D.

J Am Heart Assoc. 2013 Oct 21;2(5):e000397. doi: 10.1161/JAHA.113.000397.

12.

Omega-3 polyunsaturated Fatty acids reduce the incidence of postoperative atrial fibrillation in patients with history of prior myocardial infarction undergoing isolated coronary artery bypass grafting.

Wilbring M, Ploetze K, Bormann S, Waldow T, Matschke K.

Thorac Cardiovasc Surg. 2014 Oct;62(7):569-74. doi: 10.1055/s-0034-1371699. Epub 2014 Apr 22.

PMID:
24756483
13.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

14.

Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.

Sarmento Vasconcelos V, Macedo CR, de Souza Pedrosa A, Pereira Gomes Morais E, Porfírio GJ, Torloni MR.

Cochrane Database Syst Rev. 2016 Aug 17;(8):CD011014. doi: 10.1002/14651858.CD011014.pub2. Review.

PMID:
27536971
15.

Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.

Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM.

JAMA. 2010 Dec 1;304(21):2363-72. doi: 10.1001/jama.2010.1735. Epub 2010 Nov 15.

PMID:
21078810
16.

Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.

Mooss AN, Wurdeman RL, Sugimoto JT, Packard KA, Hilleman DE, Lenz TL, Rovang KS, Arcidi JM, Mohiuddin SM.

Am Heart J. 2004 Oct;148(4):641-8.

PMID:
15459595
17.

Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study.

Gomes JA, Ip J, Santoni-Rugiu F, Mehta D, Ergin A, Lansman S, Pe E, Newhouse TT, Chao S.

J Am Coll Cardiol. 1999 Aug;34(2):334-9.

18.

N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials.

Mariani J, Doval HC, Nul D, Varini S, Grancelli H, Ferrante D, Tognoni G, Macchia A.

J Am Heart Assoc. 2013 Feb 19;2(1):e005033. doi: 10.1161/JAHA.112.005033. Review.

19.

Fish oil supplementation for primary prevention of atrial fibrillation after coronary artery bypass graft surgery: A randomized clinical trial.

Vasheghani Farahani A, Yousefi Azar A, Goodarzynejad HR, Khorrami E, Hosseinzadeh-Attar MJ, Oshnouei S, Alizadeh Ghavidel A, Golfeshan E, Ghourban Pour F.

Int J Surg. 2017 Jun;42:41-48. doi: 10.1016/j.ijsu.2017.04.025. Epub 2017 Apr 15.

PMID:
28419884
20.

Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.

MEND-CABG II Investigators, Alexander JH, Emery RW Jr, Carrier M, Ellis SJ, Mehta RH, Hasselblad V, Menasche P, Khalil A, Cote R, Bennett-Guerrero E, Mack MJ, Schuler G, Harrington RA, Tardif JC.

JAMA. 2008 Apr 16;299(15):1777-87. doi: 10.1001/jama.299.15.joc80027. Epub 2008 Apr 1.

PMID:
18381567

Supplemental Content

Support Center